OXIGENE, INC.

Company

Oncotelic Therapeutics, Inc.

Filed

November 4, 2005

Period of Report

September 30, 2005

Accession Number

0000950135-05-006223

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →